These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4056351)

  • 1. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat.
    Jenkins SA; Grandison A; Baxter JN; Day DW; Taylor I; Shields R
    J Hepatol; 1985; 1(5):489-99. PubMed ID: 4056351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transposition of the spleen in rats with portal hypertension.
    Bengmark S; Borjesson B; Olin T
    Br J Surg; 1976 Apr; 63(4):268-71. PubMed ID: 945104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.
    Veal N; Auduberteau H; Lemarie C; Oberti F; Calès P
    Dig Dis Sci; 2001 Nov; 46(11):2367-73. PubMed ID: 11713937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats.
    Veal N; Oberti F; Moal F; Vuillemin E; Fort J; Kaassis M; Pilette C; Calès P
    J Hepatol; 2000 Mar; 32(3):434-40. PubMed ID: 10735613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue-derived mesenchymal stromal cells.
    Brückner S; Zipprich A; Hempel M; Thonig A; Schwill F; Roderfeld M; Roeb E; Christ B
    Cytotherapy; 2017 Dec; 19(12):1462-1473. PubMed ID: 29074333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cordyceps mycelia extract decreases portal hypertension in rats with dimethylnitrosamine-induced liver cirrhosis: a study on its histological basis].
    Wang XB; Liu P; Tang ZP; Li FH; Liu CH; Hu YY; Xu LM
    Zhong Xi Yi Jie He Xue Bao; 2008 Nov; 6(11):1136-44. PubMed ID: 18990339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease.
    Madden JW; Gertman PM; Peacock EE
    Surgery; 1970 Jul; 68(1):260-7; discussion 267-8. PubMed ID: 10483478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic parameters and blood gas analyses in the normal and the cirrhotic rat.
    Jostarndt L; Thermann M; Jerusalem CR; Zelder O
    Res Exp Med (Berl); 1978 Aug; 173(2):187-91. PubMed ID: 684297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sodium retention in chronic liver disease: a summary.
    Levy M
    Isr J Med Sci; 1986 Feb; 22(2):67-9. PubMed ID: 3949490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pericentral fibrosis in experimental portal hypertension in rats.
    Shibayama Y; Nakata K
    Liver; 1991 Apr; 11(2):94-9. PubMed ID: 2051907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of hepatic sinusoid capillarization during the formation of portal hypertension in fibrotic rats induced by dimethylnitrosamine].
    Lu X; Liu P; Xu GF; Liu CH; Li FH; Liu C
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):595-8. PubMed ID: 14572335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites.
    Russell RM; Boyer JL; Bagheri SA; Hruban Z
    N Engl J Med; 1974 Aug; 291(9):435-40. PubMed ID: 4843409
    [No Abstract]   [Full Text] [Related]  

  • 14. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
    Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
    Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Baxter JN; Corbett WA; Shields R
    Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma volume in two models of portal hypertension in the rat: cirrhosis of the liver and partial portal vein ligation.
    Kravetz D; Arderiu MT; Bosch J; Piera C; Setoain J; Rodés J
    Rev Esp Fisiol; 1987 Jun; 43(2):179-83. PubMed ID: 3659543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular transplantation in acute liver failure.
    Sutherland DE; Numata M; Matas AJ; Simmons RL; Najarian JS
    Surgery; 1977 Jul; 82(1):124-32. PubMed ID: 327598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.